Cartesian Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: RNAC · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1453687
| Field | Detail |
|---|---|
| Company | Cartesian Therapeutics, Inc. (RNAC) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, shareholder-vote, filing
TL;DR
Cartesian Therapeutics filed an 8-K for shareholder vote matters. Big news coming.
AI Summary
Cartesian Therapeutics, Inc. filed an 8-K on June 16, 2025, reporting on matters submitted to a vote of security holders as of June 13, 2025. The filing indicates a change in the company's reporting status or a significant corporate event requiring disclosure.
Why It Matters
This filing signals a corporate action or decision requiring shareholder approval, which could impact the company's strategic direction or financial standing.
Risk Assessment
Risk Level: medium — Filings related to shareholder votes can indicate significant corporate actions, such as mergers, acquisitions, or major strategic shifts, which carry inherent risks.
Key Players & Entities
- Cartesian Therapeutics, Inc. (company) — Registrant
- June 13, 2025 (date) — Earliest event reported
- June 16, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 7495 New Horizon Way, Frederick, MD 21703 (address) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Cartesian Therapeutics' security holders?
The filing does not specify the exact matters submitted to a vote, only that it is a 'Submission of Matters to a Vote of Security Holders'.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 13, 2025.
What is the principal executive office address for Cartesian Therapeutics, Inc.?
The principal executive office is located at 7495 New Horizon Way, Frederick, MD 21703.
What is the company's state of incorporation?
Cartesian Therapeutics, Inc. is incorporated in Delaware.
What is the filing date of this 8-K report?
This 8-K report was filed on June 16, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Cartesian Therapeutics, Inc. (RNAC).